watchTowr will use the additional funds to continue enhancing the technology that underpins its proprietary platform and to seize growth opportunities that are arising from markets outside of Southeast Asia.
AMILI, a Singapore-based precision gut microbiome company, said Wednesday it has raised$10.5 million in Series A funding to accelerate its business expansion in Southeast Asia and Greater Asia. The round was led by Vulcan Capital, the investment arm of the late Microsoft Corp co-founder Paul Allen that invests in category-leading technology, internet, and life sciences companies.